Our Newsroom

At Accord BioPharma, weโ€™re never content with the status quo.

Accord BioPharma Announces AccordConnects Inventory Management System for Hospitals and Healthcare Practices

Jan 10, 2023, 19:23 ET

DURHAM, N.C., Jan. 10, 2023 /PRNewswire/ — Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology, and critical care therapies, today announced the launch of a mobile app and web-based inventory management capability, AccordConnects, which helps healthcare practices track inventory of Accord BioPharma therapies. The software was first launched in March of this year in the form of an app available in the App Store and on Google Play, and has typically accompanied a hardware device equipped with a camera to function exclusively as a scanning device.



AccordConnects Mobile App

AccordConnects allows hospitals and healthcare practices to register Accord BioPharma products that they've received in a secure online database, create a link between their Accord BioPharma product inventory and a practice's electronic health record system, view alerts to enable optimal product lifecycle decisions, and keep a record of when inventory has been dispensed. Now, it will provide most of those same capabilities on a website created by Accord BioPharma in addition to—and in concert with—the mobile version. 

"We know that some practices do not allow their providers to download third-party applications on practice-owned devices, while others do not allow providers to use personal mobile devices during shifts," explained Nuvan Dassanaike, SVP Digital and Marketing Strategy & Operations at Accord BioPharma. "Additionally, we discovered that some HCPs prefer to perform the reporting features of AccordConnects from their computers, while others like the convenience of a mobile app. For these reasons, we worked to make our intuitive, user-friendly inventory management system available wherever was most convenient."

The web version of AccordConnects automatically syncs with the mobile version, allowing providers to securely switch between devices as needed. There are now three different ways providers can access the inventory management system—on their personal devices, on the AccordConnects website, or via an Accord-owned hardware device that comes with the capability pre-loaded.

"By harnessing the power of democratized technology, we're empowering HCPs to track their inventory in any setting, on devices they're already using every day," said Dassanaike. "It's just the latest example of our mission to go beyond biology to improve the overall experience along each touchpoint. Our near-term goal is for all the products in our portfolio to be tracked and managed via AccordConnects."

About Accord BioPharma

Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., seeks to provide affordable, accessible, patient-centric therapies in oncology, immunology, and critical care. With a focus on improving the experience, Accord BioPharma goes beyond the biology of medicine to see disease from the patients' perspective and develop high-quality therapies that impact patients' lives. The founders of Accord BioPharma have dedicated their time, passion, and resources to focusing on specialty care and treatments, proactively developing better ways of working, and delivering enhanced therapies. For more information, Visit AccordBioPharma.com.

Contact:

Nuvan Dassanaike

Senior Vice President Digital and Marketing Strategy & Operations

Cell: (412) 553-9955

SOURCE Accord BioPharma

Latest Press Releases

Thank you to everyone who joined our Accord family and the prostate cancer community to raise awareness and drive meaningful change durin...

Read more

Read more

For most of us, everyday movements happen without a secondย thought. For someone living with rheumatoid arthritis \(RA\), simpleย tasks can sometime...

Read more

Not every breast cancer decision startsโ€”or endsโ€”with a mammogram. A suspicious mammogram does not confirm cancer. Diagnosis requires a biopsy, wh...

Read more

For Global Biosimilars Week, we're celebrating the impact of this innovation across the world.ย  ย  From healthcare systems managing finite...

Read more

Pharmacists and pharmacy technicians play an important role in supporting patient careโ€”bringing expertise, collaboration, and attention to detail to...

Read more

Celebrating Champions for Change. We were honoured to attend the 2026 Champions for Change Gala by Angels for Changeโ€”an evening bringing together c...

Read more

When breast cancer spreads, the disease story changes. Bone is a common site of breast cancer metastasis, bringing new considerations to an already c...

Read more

We're committed to making quality medicines accessible to all patients who need them. Thatโ€™s why we're proud to congratulate our parent company, @[I...

Read more

Our filgrastim biosimilar expands access to supportive care for patients.ย  ย  Today, we are proud to announce that our filgrastim biosim...

Read more

What happens early in rheumatoid arthritis can influenceย what comes next. Achieving remission or low disease activity isn't just aboutย symptom con...

Read more

This September, we came together with a shared purposeโ€”ย to make a difference. Our team recently participated in a blood donation drive,ย coming t...

Read more

Treating advanced prostate cancer requires partnership โ€“ between patients and providers, between innovation and practicality. Providers need solutio...

Read more

Prostate cancer can vary from person to person, from disease progression and recurrence to treatment response andย quality of life. But how much do we...

Read more

Meet Accord: Our first biosimilar in immunology has National Preferred Formulary placement through one of the nation's largest PBMs. We're offering a ...

Read more

Connect With Us